Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Clinical Practice

Until recently, the main goal of chronic myeloid leukemia therapy was disease control with the best overall survival, which required lifelong treatment. However, currently, the treatment-free remission concept is becoming an important goal in clinical practice, and several tyrosine kinase inhibitors...

Full description

Bibliographic Details
Main Authors: Antonio Almeida, Francesca Pierdomenico, Blanca Polo Guerrero, Filipa Saraiva, Ana Montalvão, Jorge Coutinho, Mário Mariz, Teresa Melo, Maria João Santos, Alexandra Pereira, Nuno Cerveira
Format: Article
Language:English
Published: Ordem dos Médicos 2019-08-01
Series:Acta Médica Portuguesa
Subjects:
Online Access:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/11823